IPHA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Innate Pharma entered a strategic partnership with Sobi to license lacutamab for T-cell lymphomaAug 10, 2026
- Innate Pharma announces FDA clearance to proceed with TELLOMAK 3, a confirmatory Phase 3 trial of Lacutamab in CTCLNov 10, 2025
- Innate Pharma highlights preclinical antitumor activity of IPH6501 in lymphoma at EHA 2025Jun 16, 2025
- Innate Pharma highlights durable responses to Lacutamab in Sezary Syndrome and Mycosis FungoidesMay 23, 2025